- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
极度弱势行情中，投资者可暂时观望。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有265家主力机构披露2026-06-30报告期持股数据，持仓量总计2.18亿股，占流通A股13.85%
- 波段诊断：
-
技术面诊股
诊断结果：2.2技术面打败了3%的股票
技术面评分前10的股票
近期的平均成本为11.05元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为11.05元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"11.05","date":1793261762,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2026.10.30","stock":"-5.39","trade":"-0.95","ind":"-2.73"},{"date":"2026.10.29","stock":"-5.42","trade":"-2.31","ind":"-2.92"},{"date":"2026.10.28","stock":"0.91","trade":"2.17","ind":"2.02"},{"date":"2026.10.27","stock":"-3.98","trade":"-4.09","ind":"-2.50"},{"date":"2026.10.26","stock":"-1.10","trade":"0.93","ind":"-1.19"},{"date":"2026.10.23","stock":"1.93","trade":"1.99","ind":"2.79"},{"date":"2026.10.22","stock":"-3.71","trade":"-3.56","ind":"-2.96"},{"date":"2026.10.21","stock":"0.15","trade":"0.04","ind":"-0.82"},{"date":"2026.10.20","stock":"0.54","trade":"1.25","ind":"-0.14"},{"date":"2026.10.19","stock":"-3.17","trade":"-0.59","ind":"0.13"},{"date":"2026.10.16","stock":"0.53","trade":"-1.26","ind":"-0.12"},{"date":"2026.10.15","stock":"-1.12","trade":"-1.68","ind":"-2.43"},{"date":"2026.10.14","stock":"-5.18","trade":"-1.74","ind":"-1.97"},{"date":"2026.10.13","stock":"0.21","trade":"-1.62","ind":"-0.25"},{"date":"2026.10.12","stock":"-4.75","trade":"-3.02","ind":"-2.03"},{"date":"2026.10.09","stock":"4.76","trade":"1.49","ind":"0.17"},{"date":"2026.10.08","stock":"-1.05","trade":"-3.96","ind":"-2.07"},{"date":"2026.09.30","stock":"5.49","trade":"4.63","ind":"-0.11"},{"date":"2026.09.29","stock":"-0.81","trade":"-0.24","ind":"0.34"},{"date":"2026.09.28","stock":"0.15","trade":"-0.08","ind":"-3.44"},{"date":"2026.09.24","stock":"-3.55","trade":"-2.83","ind":"-2.34"}]
沃森生物,深证成指,生物制品指数
压力支撑
该股压力位为11.03元，支撑位为10.69元。
[{"text":"\u538b\u529b\u4f4d","value":"11.03","date":1793289600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"10.69","date":1793289600,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.9资金面打败了6%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月30日 20:30
| 机构今日流向(万元) | 628.67 | 机构5日流向(万元) | -2268.41 |
| 机构10日流向(万元) | -4149.62 | 机构20日流向(万元) | -13001.03 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少4616.26万股，其中基金净减仓38家，主力数没有增加，请投资者中长期谨慎为宜。
截止2026-06-30，共265家主力机构（基金262家，一般法人2家，社保基金1家），持仓量总计21836.47万股，占流通A股13.85%
其中，基金持仓与2025-12-31相比：
增仓：67家 ，增持 2778.21万股
减仓：105家 ，减持 3207.08万股
新出现在主力名单中：83家 ，持有2210.43万股
从主力名单中消失：83家 ，原持有6397.82万股
其中，基金持仓与2025-12-31相比：
增仓：67家 ，增持 2778.21万股
减仓：105家 ，减持 3207.08万股
新出现在主力名单中：83家 ，持有2210.43万股
从主力名单中消失：83家 ，原持有6397.82万股
消息面诊股
诊断结果：5.5消息面打败了29%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 沃森生物前三季度现金流大幅改善，带状疱疹mRNA疫
2026-10-30 - 股东追踪|香港中央结算有限公司新进沃森生物前十大流
2026-10-30 - 沃森生物：第六届董事会第十次会议决议公告
2026-10-29 - 沃森生物：10月28日获融资买入4911.48万元
2026-10-29 - 国寿安保创精选88ETF三季报透视：新进沃森生物、
2026-10-28 - 沃森生物：10月26日获融资买入5622.71万元
2026-10-27 - 沃森生物：公司始终聚焦主业，持续推动合成生物等新业
2026-10-26 - 千亿级产业版图中的昆明药
2026-10-26 - 行业周报|生物制品指数跌-0.96%, 跑输上证指
2026-10-23 - 沃森生物：10月22日获融资买入5826.35万元
2026-10-23
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2026-09-24 |
| 一般消息 | 募资投向 | 2026-09-19 | |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-29 |
| 一般消息 | 高管变动 | 调整 | 2026-08-17 |
| 一般消息 | 高管变动 | 连续担任公司独立董事的时间即将满6... | 2026-08-12 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-08-04 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-28 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-04-22 |
| 利好 | 分红转增 | 10派1.25元(含税) | 2026-03-28 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-03-20 |
| 利好 | 业绩预告 | 业绩预增 | 2026-01-29 |
| 一般消息 | 高管变动 | 不再担任 | 2026-01-27 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-20 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-20 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-19 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：6.2行业面打败了95%的股票
生物制品行业最新资金流向
近10日来该行业走势总体向下，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，接近大盘。
[{"date":"2026.10.30","price":"-2.73","value":"-0.95"},{"date":"2026.10.29","price":"-2.92","value":"-2.31"},{"date":"2026.10.28","price":"2.02","value":"2.17"},{"date":"2026.10.27","price":"-2.50","value":"-4.09"},{"date":"2026.10.26","price":"-1.19","value":"0.93"},{"date":"2026.10.23","price":"2.79","value":"1.99"},{"date":"2026.10.22","price":"-2.96","value":"-3.56"},{"date":"2026.10.21","price":"-0.82","value":"0.04"},{"date":"2026.10.20","price":"-0.14","value":"1.25"},{"date":"2026.10.19","price":"0.13","value":"-0.59"},{"date":"2026.10.16","price":"-0.12","value":"-1.26"},{"date":"2026.10.15","price":"-2.43","value":"-1.68"},{"date":"2026.10.14","price":"-1.97","value":"-1.74"},{"date":"2026.10.13","price":"-0.25","value":"-1.62"},{"date":"2026.10.12","price":"-2.03","value":"-3.02"},{"date":"2026.10.09","price":"0.17","value":"1.49"},{"date":"2026.10.08","price":"-2.07","value":"-3.96"},{"date":"2026.09.30","price":"-0.11","value":"4.63"},{"date":"2026.09.29","price":"0.34","value":"-0.24"},{"date":"2026.09.28","price":"-3.44","value":"-0.08"},{"date":"2026.09.24","price":"-2.34","value":"-2.83"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 近岸蛋白 | 20.40% | 40.93% | 5.4分 |
| 2 | - | 10.76% | -9.00% | 分 |
| 3 | 我武生物 | 7.57% | 10.68% | 5.8分 |
| 4 | 智飞生物 | 3.69% | 4.82% | 5.4分 |
| 5 | 通化东宝 | 2.07% | 1.41% | 6.1分 |
| 6 | 天坛生物 | 1.74% | 0.57% | 6.0分 |
| 8 | 长春高新 | -1.64% | -3.32% | 5.2分 |
| 10 | 派林生物 | -3.79% | -2.39% | 5.2分 |
| 12 | 辽宁成大 | -5.74% | -1.83% | 5.2分 |
| 14 | 智翔金泰 | -6.01% | -4.06% | 4.7分 |
| 16 | 安科生物 | -6.28% | -3.48% | 4.8分 |
| 18 | 康弘药业 | -7.93% | -5.76% | 4.2分 |
| 20 | 赛升药业 | -9.87% | -1.03% | 4.3分 |
| 22 | 康希诺 | -10.86% | -3.00% | 4.1分 |
| 24 | 优宁维 | -11.87% | -3.67% | 4.7分 |
| 26 | 康华生物 | -12.83% | -1.10% | 4.7分 |
| 28 | 百克生物 | -13.07% | -3.62% | 4.8分 |
| 30 | 博晖创新 | -13.93% | -4.91% | 4.3分 |
| 32 | 百普赛斯 | -14.75% | 17.51% | 5.3分 |
| 34 | 康辰药业 | -15.55% | -9.98% | 4.7分 |
| 36 | 四环生物 | -16.08% | -10.47% | 4.2分 |
| 38 | 欧林生物 | -16.62% | -2.23% | 5.3分 |
| 40 | 君实生物 | -16.97% | -8.61% | 5.3分 |
| 42 | 诺诚健华 | -18.62% | -8.65% | 4.7分 |
| 44 | 沃森生物 | -19.81% | -14.25% | 3.9分 |
| 46 | 昊帆生物 | -20.07% | -8.62% | 4.7分 |
| 48 | 百奥泰 | -21.46% | -9.66% | 4.7分 |
| 50 | 艾迪药业 | -25.20% | -15.87% | 4.7分 |
| 52 | 华兰疫苗 | -27.61% | -23.10% | 3.9分 |
| 54 | 万泽股份 | -29.46% | -16.56% | 4.7分 |
| 56 | 金迪克 | -34.93% | -11.76% | 3.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 32/74 ， 29/74。
[{"date":"2026-09-30","value":"0.10","vol":"-3.86"},{"date":"2026-06-30","value":"0.69","vol":"-7.86"},{"date":"2026-03-31","value":"1.38","vol":"-6.34"},{"date":"2025-12-31","value":"1.97","vol":"-12.02"},{"date":"2025-09-30","value":"1.71","vol":"-9.71"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.10 | 0.69 | 1.38 | 1.97 | 1.71 |
| 行业(%) | -3.86 | -7.86 | -6.34 | -12.02 | -9.71 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"66.69","vol":"63.98"},{"date":"2026-06-30","value":"68.79","vol":"56.17"},{"date":"2026-03-31","value":"68.47","vol":"60.27"},{"date":"2025-12-31","value":"74.56","vol":"65.27"},{"date":"2025-09-30","value":"71.69","vol":"67.57"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
66.69 | 68.79 | 68.47 | 74.56 | 71.69 |
| 行业(%) | 63.98 | 56.17 | 60.27 | 65.27 | 67.57 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 45/74 ， 42/74。
[{"date":"2026-09-30","value":"-33.27","vol":"16.67"},{"date":"2026-06-30","value":"-27.72","vol":"30.57"},{"date":"2026-03-31","value":"-3.98","vol":"291.45"},{"date":"2025-12-31","value":"-14.29","vol":"39.10"},{"date":"2025-09-30","value":"-19.73","vol":"44.08"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-33.27 | -27.72 | -3.98 | -14.29 | -19.73 |
| 行业(%) | 16.67 | 30.57 | 291.45 | 39.10 | 44.08 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"-95.39","vol":"49.44"},{"date":"2026-06-30","value":"25.56","vol":"18.61"},{"date":"2026-03-31","value":"4082.41","vol":"71.92"},{"date":"2025-12-31","value":"25.03","vol":"36.03"},{"date":"2025-09-30","value":"-36.24","vol":"43.94"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-95.39 | 25.56 | 4082.41 | 25.03 | -36.24 |
| 行业(%) | 49.44 | 18.61 | 71.92 | 36.03 | 43.94 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 41/74 ， 27/74。
[{"date":"2026-09-30","value":"0.10","vol":"0.21"},{"date":"2026-06-30","value":"0.07","vol":"0.14"},{"date":"2026-03-31","value":"0.04","vol":"0.06"},{"date":"2025-12-31","value":"0.18","vol":"0.30"},{"date":"2025-09-30","value":"0.12","vol":"0.21"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.10 | 0.07 | 0.04 | 0.18 | 0.12 |
| 行业(次) | 0.21 | 0.14 | 0.06 | 0.30 | 0.21 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.64","vol":"0.92"},{"date":"2026-06-30","value":"0.44","vol":"0.62"},{"date":"2026-03-31","value":"0.25","vol":"0.28"},{"date":"2025-12-31","value":"0.93","vol":"1.26"},{"date":"2025-09-30","value":"0.75","vol":"0.86"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.64 | 0.44 | 0.25 | 0.93 | 0.75 |
| 行业(次) | 0.92 | 0.62 | 0.28 | 1.26 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"57.31","vol":"2.33"},{"date":"2026-06-30","value":"49.74","vol":"-1266.35"},{"date":"2026-03-31","value":"-4.56","vol":"-144.81"},{"date":"2025-12-31","value":"58.80","vol":"-237.25"},{"date":"2025-09-30","value":"-6.55","vol":"-11.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 57.31 | 49.74 | -4.56 | 58.80 | -6.55 |
| 行业 | 2.33 | -1266.35 | -144.81 | -237.25 | -11.00 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.89","vol":"1.58"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.24","vol":"1.73"},{"date":"2025-09-30","value":"","vol":"0.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.89 | - | 1.24 | - |
| 行业 | 0.00 | 1.58 | 0.00 | 1.73 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 1/74 ， 10/74。
[{"date":"2026-09-30","value":"2.01","vol":"6.07"},{"date":"2026-06-30","value":"2.07","vol":"5.75"},{"date":"2026-03-31","value":"2.16","vol":"6.58"},{"date":"2025-12-31","value":"2.35","vol":"5.74"},{"date":"2025-09-30","value":"3.52","vol":"5.84"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.01 | 2.07 | 2.16 | 2.35 | 3.52 |
| 行业 | 6.07 | 5.75 | 6.58 | 5.74 | 5.84 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"1.39","vol":"4.57"},{"date":"2026-06-30","value":"1.47","vol":"4.33"},{"date":"2026-03-31","value":"1.67","vol":"5.09"},{"date":"2025-12-31","value":"1.85","vol":"4.39"},{"date":"2025-09-30","value":"2.41","vol":"4.70"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.39 | 1.47 | 1.67 | 1.85 | 2.41 |
| 行业 | 4.57 | 4.33 | 5.09 | 4.39 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 16/74 ， 17/74。
[{"date":"2026-09-30","value":"30.23","vol":"27.69"},{"date":"2026-06-30","value":"30.18","vol":"29.58"},{"date":"2026-03-31","value":"29.79","vol":"29.49"},{"date":"2025-12-31","value":"20.99","vol":"29.33"},{"date":"2025-09-30","value":"17.42","vol":"26.96"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
30.23 | 30.18 | 29.79 | 20.99 | 17.42 |
| 行业(%) | 27.69 | 29.58 | 29.49 | 29.33 | 26.96 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.46","vol":"1.78"},{"date":"2026-06-30","value":"0.45","vol":"1.35"},{"date":"2026-03-31","value":"0.45","vol":"2.52"},{"date":"2025-12-31","value":"0.29","vol":"1.42"},{"date":"2025-09-30","value":"0.24","vol":"0.56"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.46 | 0.45 | 0.45 | 0.29 | 0.24 |
| 行业(%) | 1.78 | 1.35 | 2.52 | 1.42 | 0.56 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"7.29","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.19","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.42","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.78","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]